Allergan Aesthetics
Stephanie Manson Brown currently serves as the Head of Clinical Development & Scientific Innovation and Skincare R&D at AbbVie since May 2019, and also holds the position of Vice President, Global Therapeutic Area Head Clinical Development for Aesthetics. Additionally, since May 2020, Manson Brown has been the Vice President and Head of Clinical Development & Scientific Innovation at Allergan Aesthetics. Prior experience includes roles at Allergan from February 2014 to May 2019, where responsibilities encompassed Global Therapeutic Area Head Clinical Development and Global Head of Medical Affairs for Aesthetics and Medical Dermatology. Earlier positions at Pfizer featured roles such as Medical Affairs Team Lead Customer Marketing UK and Medical Adviser. Manson Brown began a medical career at Novo Nordisk A/S as a Medical Advisor from April 2008 to August 2010. Educational qualifications include an MFPM in Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine, MRCS in Surgery from the Royal College of Surgeons (Edin), and an MBBS in Medicine from the University of Newcastle.
This person is not in any teams
This person is not in any offices
Allergan Aesthetics
7 followers
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. At Allergan Aesthetics™ we believe in the remarkable impact confidence can have on the lives, businesses, and careers of those we serve through our history of a company built on patient-care, education and support of our customers, and our commitment to putting the patients we serve first. That’s why we dedicate ourselves, every day, united by a single purpose: empowering confidence. For our customers, their patients and one another. Review our LinkedIn community guidelines at https://news.abbvie.com/social-media/